Login / Signup

Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events.

Dario CalderoneSalvatore IngalaMaria Sara MauroDominick J AngiolilloDavide Capodanno
Published in: Expert review of cardiovascular therapy (2021)
inhibitor is used, hence reducing the bleeding risk with no rebound in thrombotic events.
Keyphrases
  • cardiovascular events
  • coronary artery disease
  • cardiovascular disease
  • atrial fibrillation
  • low dose
  • type diabetes
  • percutaneous coronary intervention